Phase 1 Graves Disease Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
Graves Disease
Merida Biosciences100 enrolled7 locationsNCT07305818
Recruiting
Phase 1
Study of BHV-1300 in Graves' Disease
Graves Disease
Biohaven Therapeutics Ltd.15 enrolled13 locationsNCT06980649
Recruiting
Phase 1
A Study of GensSci098 in Subjects With Graves' Disease
SafetyGraves DiseaseTolerability+1 more
Changchun GeneScience Pharmaceutical Co., Ltd.24 enrolled1 locationNCT07286656